Candel Therapeutics, Inc. (CADL) — Cash & Equivalents
| Fiscal Year | Cash & Equivalents | Change YoY |
|---|---|---|
| 2025 | $119.73M | +16.6% |
| 2024 | $102.65M | +189.9% |
| 2023 | $35.41M | -49.5% |
| 2022 | $70.06M | -15.2% |
| 2021 | $82.64M | +135.8% |
| 2020 | $35.05M | — |
| Fiscal Year | Cash & Equivalents | Change YoY |
|---|---|---|
| 2025 | $119.73M | +16.6% |
| 2024 | $102.65M | +189.9% |
| 2023 | $35.41M | -49.5% |
| 2022 | $70.06M | -15.2% |
| 2021 | $82.64M | +135.8% |
| 2020 | $35.05M | — |